Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Shank

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Hospital Pharmacy|May 11, 1982
Penicillin skin test kits prepared by pharmacy serviceW A Shank
Journal of the American Geriatrics Society|February 11, 1992
Recombinant hemopoietic growth factors: comparative hemopoietic response in younger and older subjectsW A Shank, L Balducci
Hospital Pharmacy|June 9, 1986
A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implicationsW P Petros, W A Shank
Southern Medical Journal|March 1, 1986
Oral sulfonylureas for the treatment of type II diabetes: an updateW A Shank, A D Morrison
Therapeutic Drug Monitoring|January 1, 1984
Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzerP R Oeltgen, W A Shank, R A Blouin, et al.
Therapeutic Drug Monitoring|January 1, 1982
Evaluation of gentamicin pharmacokinetics during peritoneal dialysisS R Hamann, P R Oeltgen, W A Shank, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Hospital Pharmacy|May 11, 1982
Penicillin skin test kits prepared by pharmacy serviceW A Shank
Journal of the American Geriatrics Society|February 11, 1992
Recombinant hemopoietic growth factors: comparative hemopoietic response in younger and older subjectsW A Shank, L Balducci
Hospital Pharmacy|June 9, 1986
A standardized parenteral nutrition solution: prescribing, use, processing, and material cost implicationsW P Petros, W A Shank
Southern Medical Journal|March 1, 1986
Oral sulfonylureas for the treatment of type II diabetes: an updateW A Shank, A D Morrison
Therapeutic Drug Monitoring|January 1, 1984
Clinical evaluation of the Abbott TDx fluorescence polarization immunoassay analyzerP R Oeltgen, W A Shank, R A Blouin, et al.
Therapeutic Drug Monitoring|January 1, 1982
Evaluation of gentamicin pharmacokinetics during peritoneal dialysisS R Hamann, P R Oeltgen, W A Shank, et al.
Pageof 1